Purchases and Sales Made in Q1 2024 in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during Q1 2024. The information is specifically focused on institutions that hold shares of Blueprint Medicines Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 14, 2024
Q1 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-258K- 16.43% |
$18.9M - $25.7M
|
1.31M
$170M
|
|
May 15, 2024
Q1 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-383K- 13.3% |
$28M - $38.2M
|
2.5M
$323M
|
|
May 15, 2024
Q1 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-596K- 37.25% |
$43.6M - $59.4M
|
1M
$130M
|